In these models, the replacement of adiponectin improved insulin resistance, fatty acid oxidation, and energy consumption, leading to a reduction of triglyceride levels in muscle and liver tissue [92, 93]. The gene discussed is ADIPOQ; the disease is Insulin resistance.